Breast CA Risk Up With Recent Hormonal Contraceptive Use

Share this content:
Breast CA Risk Up With Recent Hormonal Contraceptive Use
Breast CA Risk Up With Recent Hormonal Contraceptive Use

THURSDAY, Dec. 7, 2017 (HealthDay News) -- Women who currently use or recently used contemporary hormonal contraceptives have increased risk of breast cancer, although the absolute increase is small, according to a study published in the Dec. 7 issue of the New England Journal of Medicine.

Lina S. Mørch, Ph.D., from the University of Copenhagen in Denmark, and colleagues examined the correlations between hormonal contraception use and the risk of invasive breast cancer in 1.8 million women from Denmark aged 15 to 49 years.

The researchers identified 11,517 cases of breast cancer during 19.6 million person-years of follow-up. The relative risk of breast cancer was 1.20 (95 percent confidence interval [CI], 1.14 to 1.26) among all current and recent users of hormonal contraception, compared with women who had never used hormonal contraception. Risk increased with duration of use from 1.09 (95 percent CI, 0.96 to 1.23) with less than one year to 1.38 (95 percent CI, 1.26 to 1.51) with greater than 10 years (P = 0.002). Women who had used hormonal contraceptives for five years or more had a higher risk of breast cancer after discontinuing hormonal contraception than women who had not used hormonal contraceptives.

"The overall absolute increase in breast cancers diagnosed among current and recent users of any hormonal contraceptive was 13 (95 percent CI, 10 to 16) per 100,000 person-years, or approximately one extra breast cancer for every 7,690 women using hormonal contraception for one year," the authors write.

Two authors disclosed financial ties to the Novo Nordisk Foundation, which funded the study.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve ...

Diagnostic error is the most common cause of medical errors that patients report

HbA1c Variability Is a Strong Predictor of Mortality in T2DM

HbA1c Variability Is a Strong Predictor of Mortality ...

HbA1c variability is a powerful, independent measure, regardless of how it is measured

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Actual probability of death for patients on liver transplant wait list underestimated by up to 17%

is free, fast, and customized just for you!




Already a member?

Sign In Now »